NPS Pharmaceuticals to Present at BIO CEO & Investor Conference

    BEDMINSTER, N.J., Feb. 4 /CNW/ -- NPS Pharmaceuticals, Inc. (Nasdaq:  
NPSP) announced today that Francois Nader, M.D., executive vice president and
chief operating officer, is scheduled to present at the 10th Annual BIO CEO
and Investor Conference in New York on Monday, February 11, 2008 at 1:15 p.m.
ET.  The presentation will be available as a live webcast with a replay
available approximately three hours after the presentation has concluded. 
Interested parties may access the webcast from the NPS website,
    About NPS Pharmaceuticals
    NPS Pharmaceuticals is a biopharmaceutical company focused on the
development and commercialization of small molecules and recombinant proteins
as drugs, primarily for the treatment of metabolic, bone and mineral, and
central nervous system disorders. The Company has drug candidates in various
stages of clinical development. Additional information is available on the NPS

For further information:

For further information: Susan Mesco of NPS Pharmaceuticals, Inc., 
+1-908-450-5516 Web Site:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890